Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT2016052428043N1
IRCT2016052428043N1Completed未知

Efficacy of combined extract of Nigella Sativa and Thymus Vulgaris on refractory seizures in children

Vice chancellor of Ahvaz Jundishapur University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
3 years to 18 years (—)
Sex
All

Inclusion Criteria

  • •Inclusion criteria : children with a diagnosis of refractory seizures; having at least two episodes of seizures during one month prior to study entry; regular consumption of previous antiepileptic drugs.
  • •Exclusion criteria ; occurrence of adverse side effects such as nausea and vomiting; increase the number and duration of seizure after starting NS and TV; and dissatisfaction to continue participation in study.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor of Ahvaz Jundishapur University of Medical Sciences

Similar Trials

Recruiting
Phase 2
Effect of Nigella sativa extraction supplement in benign prostatic hyperplasia
IRCT20201108049311N4Tabriz University of Medical Sciences60
Not yet recruiting
Phase 1
Comparison of therapeutic effect of nigella sativa and corticosterioid in orabase on oral erosive atrophic lichen planusLichen planuslichen planus.
IRCT20080907001222N2Mashhad University of Medical Sciences40
Completed
Unknown
Comparison of effectiveness of nigella sativa mouthwash with chlorhexidine mouthwash on improvement of gingivitis
IRCT20221212056786N2Yazd University of Medical Sciences36
Recruiting
Phase 2
Comparing the effect of nigella sativa powder and cuminum cyminum powder on eradication of helicobacter pylori, dyspepsia and quality of life in patients with this infectioCondition 1: Dyspepsia. Condition 2: Helicobacter pylori infection.Disease of stomach and duodenum, unspecifiedDyspepsia
IRCT2017091636204N1Shiraz University of Medical Sciences90
Completed
Phase 3
Effect of Nigella Sativa supplement on the expression of genes involved in insulin resistanceObesity.Overweight and obesity
IRCT20180430039475N1Yazd University of Medical Sciences40